Literature DB >> 3499151

Hormonal regulation of serum alpha 1-antitrypsin and hepatic alpha 1-antitrypsin mRNA in rats.

S J Schwarzenberg1, H L Sharp, S A Berry, R D Manthei, S Seelig.   

Abstract

We evaluated the effects of pituitary dependent hormones on alpha 1-antitrypsin in male rats. Hepatic alpha 1-antitrypsin mRNA was measured by in vitro translation and by specific hybridization with a mouse cDNA alpha 1-antitrypsin probe. Hypophysectomy caused a 50-75% decrease in serum elastase inhibitory capacity (measuring functional alpha 1-antitrypsin) and hepatic alpha 1-antitrypsin mRNA content. In hypophysectomized animals, no increase in elastase inhibitory capacity or alpha 1-antitrypsin mRNA levels by translation was found when met-human growth hormone alone or corticosterone, dihydrotestosterone and thyroxine were given together. Growth hormone increased alpha 1-antitrypsin mRNA by hybridization to a small extent. Addition of growth hormone to the combination of corticosterone, dihydrotestosterone, and thyroxine increased serum elastase inhibitory capacity and alpha 1-antitrypsin mRNA. We conclude that growth hormone acts synergistically with the other pituitary dependent hormones to regulate serum and hepatic mRNA levels of alpha 1-antitrypsin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499151     DOI: 10.1016/s0006-291x(87)80160-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects.

Authors:  Juan Ding; Shigeru Okada; Jens Otto Lunde Jørgensen; John J Kopchick
Journal:  Proteomics       Date:  2011-07-27       Impact factor: 3.984

2.  Two thyroid hormone-mediated gene expression patterns in vivo identified by cDNA expression arrays in rat.

Authors:  J M Weitzel; C Radtke; H J Seitz
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

Review 3.  Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Authors:  Jennifer A Dickens; David A Lomas
Journal:  Drug Des Devel Ther       Date:  2011-08-17       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.